# Federica Di Palma

> Federica Di Palma is a grant investor at Genome British Columbia backing Medical and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Genome British Columbia](https://shizune.co/investors/profile/genome-british-columbia)
- Total investments: 1
- Last investment: Mar 2022
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/federica-di-palma-423ba88

Federica Di Palma is a grant investor at Genome British Columbia focused on Medical and Biotechnology. Federica Di Palma

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Avivo Biomedical | Avivo Biomedical operates as a preclinical-stage company, has identified enzymes that convert the cell surface antigens that determine a person’s blood group to group O, the universal donor type. | $250K | Grant | Mar 31, 2022 |  |

1 of 1 investments shown.

## About Genome British Columbia

VC Fund · Vancouver, Canada

Genome BC, a non-profit research organization, leads genomics innovation on Canada’s West Coast and facilitates the integration of genomics into society. Their major investors are the Province of British Columbia and the Government of Canada through Genome Canada and Western Economic Diversification Canada. This funding is complemented bypartnerships with many national and international public and private funding organizations to drive BC’s bioeconomy.

3 contacts available at Genome British Columbia.

| Name | Title | Profile |
| --- | --- | --- |
| Tony Brooks | CFO& VP Entrepreneurship & Commercialization | https://shizune.co/investors/profile/tony-brooks-4e9b |
| Catalina Lopez-Correa | Chief Scientific Officer & Vice President Sectors | https://shizune.co/investors/profile/catalina-lopez-correa |
| Federica Di Palma | Chief Scientific Officer and Vice President Sectors | https://shizune.co/investors/profile/federica-di-palma |

## Similar investors

### Similar stage
- [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund
- [Business Finland](https://shizune.co/investors/profile/tekes) — VC Fund

## FAQ

### What does Federica Di Palma invest in?

Federica Di Palma invests primarily in Medical and Biotechnology startups, most often at Grant stage. Most of the 1 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Federica Di Palma last invest?

The most recent investment recorded for Federica Di Palma closed in Mar 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co